Incisional hernias post cytoreductive surgery/peritonectomy and hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis.
Cytoreductive surgery
Hyperthermic/heated intraperitoneal chemotherapy
Incisional hernia
Surgical oncology
Journal
Hernia : the journal of hernias and abdominal wall surgery
ISSN: 1248-9204
Titre abrégé: Hernia
Pays: France
ID NLM: 9715168
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
received:
18
06
2023
accepted:
07
08
2023
medline:
4
10
2023
pubmed:
1
9
2023
entrez:
31
8
2023
Statut:
ppublish
Résumé
Cytoreductive surgery (CRS) is often combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of peritoneal tumour deposits. Considering CRS, the evidence relating the large incisions, local chemotherapy and abdominal wall trauma to incisional hernias (IH) has not been synthesized. This systematic review and meta-analysis was conducted to examine the proportion of IH present in patients post CRS and the effect HIPEC had on these rates. PubMed, EMBASE, and Cochrane Central Registry of Trials were searched up to June 2023 to examine studies relating IH and CRS plus or minus HIPEC. The most up to date PRISMA guidelines were followed. Pertinent clinical information was synthesized in tabular form. A meta-analysis reporting the pooled proportions of IH post CRS plus or minus HIPEC, the odds of IH in HIPEC versus non-HIPEC CRS and the difference in follow-up time between groups was conducted. Nine studies comprising 1416 patients were included. The pooled proportion of IH post CRS was 12% (95% confidence interval (CI) 8-16%) in HIPEC and 7% (95% CI 4-10%) in non-HIPEC patients and 11% (95% CI 7-14%) overall. Previously reported rates of IH in midline laparotomy range from 10 to 30%. The odds of IH in the HIPEC was 1.9 times higher compared to non-HIPEC cohorts however this was not statistically significant (odds ratio (OR) 1.9, 95% 0.7-5.2; p = 0.21). There was no significant difference in average follow-up times between HIPEC and non-HIPEC cohorts. IH post CRS plus or minus HIPEC were in the expected range for midline laparotomies. IH in patients receiving HIPEC may occur at a greater proportion than in non-HIPEC patients, however, there were too few studies in our meta-analysis to determine this with statistical significance.
Identifiants
pubmed: 37653188
doi: 10.1007/s10029-023-02859-z
pii: 10.1007/s10029-023-02859-z
pmc: PMC10533625
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1067-1083Informations de copyright
© 2023. The Author(s).
Références
Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7(1):69–76
pubmed: 16389186
doi: 10.1016/S1470-2045(05)70539-8
Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN et al (2012) Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456
pubmed: 22614976
doi: 10.1200/JCO.2011.39.7166
Ray MD, Dhall K (2021) Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of peritoneal surface malignancies—An evidence-based review. Curr Probl Cancer 45(6):100737. https://doi.org/10.1016/j.currproblcancer.2021.100737 . (PMID: 34116836)
doi: 10.1016/j.currproblcancer.2021.100737
pubmed: 34116836
Mehta SS, Bhatt A, Glehen O (2016) Cytoreductive surgery and peritonectomy procedures. Indian J Surg Oncol 7(2):139–51. https://doi.org/10.1007/s13193-016-0505-5 . (PMID: 27065704; PMCID: PMC4818624)
doi: 10.1007/s13193-016-0505-5
pubmed: 27065704
pmcid: 4818624
Sparks DS, Morris B, Xu W, Fulton J, Atkinson V, Meade B, Lutton N (2015) Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix. Int Surg 100(1):21–28. https://doi.org/10.9738/INTSURG-D-14-00089.1 . (PMID:25594636;PMCID:PMC4301290)
doi: 10.9738/INTSURG-D-14-00089.1
pubmed: 25594636
pmcid: 4301290
McConnell YJ, Mack LA, Francis WP, Ho T, Temple WJ (2013) HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy. J Surg Oncol 107(6):591–596
pubmed: 23129533
doi: 10.1002/jso.23276
Yan TD, Black D, Savady R, Sugarbaker PH (2007) A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol 14(2):484–492
pubmed: 17054002
doi: 10.1245/s10434-006-9182-x
Kusamura S, Baratti D, Virzì S, Bonomi S, Iusco DR, Grassi A et al (2013) Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres. J Surg Oncol 107(4):312–319
pubmed: 22926536
doi: 10.1002/jso.23231
Mehta SS, Gelli M, Agarwal D, Goéré D (2016) Complications of cytoreductive surgery and HIPEC in the treatment of peritoneal metastases. Indian J Surg Oncol 7(2):225–229
pubmed: 27065713
pmcid: 4818615
doi: 10.1007/s13193-016-0504-6
Cascales Campos PA, González-Gil A, Gómez-Ruiz AJ, Gil-Gómez E, Alconchel-Gago F, Navarro-Barrios A et al (2020) Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies. Hernia 24(2):257–263
pubmed: 31069579
doi: 10.1007/s10029-019-01962-4
Gusani NJ, Cho SW, Colovos C, Seo S, Franko J, Richard SD et al (2008) Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol 15(3):754–763
pubmed: 18080166
doi: 10.1245/s10434-007-9701-4
Baratti D, Kusamura S, Laterza B, Balestra MR, Deraco M (2010) Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Gastrointest Oncol 2(1):36–43
pubmed: 21160815
pmcid: 2999156
doi: 10.4251/wjgo.v2.i1.36
Kingsnorth A (2006) The management of incisional hernia. Ann R Coll Surg Engl 88(3):252–260. https://doi.org/10.1308/003588406X106324 . (PMID:16719992;PMCID:PMC1963672)
doi: 10.1308/003588406X106324
pubmed: 16719992
pmcid: 1963672
Baucom RB, Ousley J, Beveridge GB et al (2016) Cancer survivorship: defining the incidence of incisional hernia after resection for intra-abdominal malignancy. Ann Surg Oncol 23:764–771
pubmed: 27743227
doi: 10.1245/s10434-016-5546-z
Gignoux B, Bayon Y, Martin D, Phan R, Augusto V, Darnis B, Sarazin M (2021) Incidence and risk factors for incisional hernia and recurrence: retrospective analysis of the French national database. Colorectal Dis 23(6):1515–1523. https://doi.org/10.1111/codi.15581 . (PMID: 33570808)
doi: 10.1111/codi.15581
pubmed: 33570808
Bosanquet DC, Ansell J, Abdelrahman T, Cornish J, Harries R, Stimpson A et al (2015) Systematic review and meta-regression of factors affecting midline incisional hernia rates: analysis of 14,618 patients. PLoS One 10(9):e0138745. https://doi.org/10.1371/journal.pone.0138745
doi: 10.1371/journal.pone.0138745
pubmed: 26389785
pmcid: 4577082
Bhagwandin SB, Naffouje S, Salti G (2015) Delayed presentation of major complications in patients undergoing cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy following hospital discharge. J Surg Oncol 111(3):324–327. https://doi.org/10.1002/jso.23834 . (PMID: 25557653)
doi: 10.1002/jso.23834
pubmed: 25557653
Chua TC, Yan T, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: A systematic review of morbidity and mortality. Ann Surg 249(6):900–907. https://doi.org/10.1097/SLA.0b013e3181a45d86
doi: 10.1097/SLA.0b013e3181a45d86
pubmed: 19474692
Ravn S, Thaysen HV, Harsløf S, Sørensen MM, Iversen LH (2018) Incisional hernia and its impact on health-related quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a national prospective cohort study. World J Surg Oncol 16(1):1–10
doi: 10.1186/s12957-018-1382-x
Struller F, Koenigsrainer I, Horvath P, Koenigsrainer A, Beckert S (2017) Abdominal wall morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Scand J Surg 106(4):294–298
pubmed: 28737098
doi: 10.1177/1457496917690989
Tuttle TM, Huang JL, Kizy S, Altman AM, Nalluri H, Marmor S et al (2019) Incidence and predictors of incisional hernia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperth 36(1):811–815
doi: 10.1080/02656736.2019.1641634
Pamela K, Matthias Z, Reinhold KR, Julia P, Peter M, Alexander P, Dietmar Ö (2018) Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a single-center experience in Austria. J Gastrointest Surg 22(5):884–893. https://doi.org/10.1007/s11605-017-3661-1 . (PMID: 29363016; PMCID: PMC5954007)
doi: 10.1007/s11605-017-3661-1
pubmed: 29363016
pmcid: 5954007
Ahn BK (2012) Risk factors for incisional hernia and parastomal hernia after colorectal surgery. J Korean Soc Coloproctol 28(6):280–1. https://doi.org/10.3393/jksc.2012.28.6.280 . (PMID: 23346503; PMCID: PMC3548139)
doi: 10.3393/jksc.2012.28.6.280
pubmed: 23346503
pmcid: 3548139
Neuwirth MG, Alexander HR, Karakousis GC (2016) Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective. J Gastrointest Oncol 7(1):18–28. https://doi.org/10.3978/j.issn.2078-6891.2015.106 . (PMID:26941981;PMCID:PMC4754315)
doi: 10.3978/j.issn.2078-6891.2015.106
pubmed: 26941981
pmcid: 4754315
Itatsu K et al (2014) Incidence of and risk factors for incisional hernia after abdominal surgery. Br J Surg 101(11):1439–1447
pubmed: 25123379
doi: 10.1002/bjs.9600
Wenzelberg C et al (2023) Abdominal closure with reinforcing suture decreases incisional hernia incidence after CRS/HIPEC. J Abdom Wall Surg. https://doi.org/10.3389/jaws.2023.11188
doi: 10.3389/jaws.2023.11188
Wenzelberg C, Petersson U, Syk I, Ekberg O, Rogmark P (2023) Abdominal closure with reinforcing suture decreases incisional hernia incidence after CRS/HIPEC. J Abdom Wall Surg. https://doi.org/10.3389/jaws.2023.11188
doi: 10.3389/jaws.2023.11188
Morano WF, Khalili M, Chi DS, Bowne WB, Esquivel J (2018) Clinical studies in CRS and HIPEC: trials, tribulations, and future directions-A systematic review. J Surg Oncol 117(2):245–259. https://doi.org/10.1002/jso.24813 . (PMID: 29120491; PMCID: PMC6692902)
doi: 10.1002/jso.24813
pubmed: 29120491
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol 134:178–189
pubmed: 33789819
doi: 10.1016/j.jclinepi.2021.03.001
Brown D (2020) A review of the PubMed PICO Tool: using evidence-based practice in health education. Health Promot Pract 21(4):496–498
pubmed: 31874567
doi: 10.1177/1524839919893361
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan—A web and mobile app for systematic reviews. Syst Rev 5(1):210
pubmed: 27919275
pmcid: 5139140
doi: 10.1186/s13643-016-0384-4
Parikh R, Shah S, Dhurandhar V, Alzahrani N, Fisher OM, Arrowaili A et al (2019) An analysis of the morbidity associated with abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Eur J Surg Oncol 45(3):394–399
pubmed: 30638806
doi: 10.1016/j.ejso.2018.12.020
Spencer RJ, Hayes KD, Rose S, Zhao Q, Rathouz PJ, Rice LW et al (2015) Risk factors for early and late-occurring incisional hernias after primary laparotomy for ovarian cancer. Obstet Gynecol 125(2):407
pubmed: 25568995
pmcid: 6392024
doi: 10.1097/AOG.0000000000000610
Wong J, Koch AL, Deneve JL, Fulp W, Tanvetyanon T, Dessureault S (2014) Repeat cytoreductive surgery and heated intraperitoneal chemotherapy may offer survival benefit for intraperitoneal mesothelioma: a single institution experience. Ann Surg Oncol 21:1480–1486
pubmed: 24158467
doi: 10.1245/s10434-013-3341-7
Wells G, Shea B, O’Connell D, Peterson j, Welch V, Losos M, et al. (2000) The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis
Barker TH, Migliavaca CB, Stein C, Colpani V, Falavigna M, Aromataris E et al (2021) Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol 21(1):189
pubmed: 34544368
pmcid: 8451728
doi: 10.1186/s12874-021-01381-z
Nyaga VN, Arbyn M, Aerts M (2014) Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health 72(1):39
pubmed: 25810908
pmcid: 4373114
doi: 10.1186/2049-3258-72-39
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
pubmed: 12958120
pmcid: 192859
doi: 10.1136/bmj.327.7414.557
Borenstein M, Hedges LV, Higgins JP, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods 1(2):97–111
pubmed: 26061376
doi: 10.1002/jrsm.12
Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343:d4002
pubmed: 21784880
doi: 10.1136/bmj.d4002
Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36(3):1–48
doi: 10.18637/jss.v036.i03
Lin L, Chu H (2020) Meta-analysis of proportions using generalized linear mixed models. Epidemiology 31(5):713–717
pubmed: 32657954
pmcid: 7398826
doi: 10.1097/EDE.0000000000001232
Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 14(1):135
pubmed: 25524443
pmcid: 4383202
doi: 10.1186/1471-2288-14-135
Lewcun JA, Pauli EM, Pameijer C (2020) Incisional hernia formation can be reduced following hyperthermic intraperitoneal chemotherapy with increased suture length to wound length ratio fascial closure. Int J Abdom Wall Hernia Surg 3(4):117
doi: 10.4103/ijawhs.ijawhs_30_20
Fink C, Baumann P, Wente MN, Knebel P, Bruckner T, Ulrich A et al (2014) Incisional hernia rate 3 years after midline laparotomy. Br J Surg 101(2):51–54
pubmed: 24281948
doi: 10.1002/bjs.9364
Kohler A, Lavanchy JL, Lenoir U, Kurmann A, Candinas D, Beldi G (2019) Effectiveness of prophylactic intraperitoneal mesh implantation for prevention of incisional hernia in patients undergoing open abdominal surgery: a randomized clinical trial. JAMA Surg 154(2):109–115
pubmed: 30476940
doi: 10.1001/jamasurg.2018.4221
O’Dwyer PJ, Courtney CA (2003) Factors involved in abdominal wall closure and subsequent incisional hernia. Surgeon 1(1):17–22
pubmed: 15568420
doi: 10.1016/S1479-666X(03)80004-5
Höer J, Lawong G, Klinge U, Schumpelick V (2002) Factors influencing the development of incisional hernia. A retrospective study of 2983 laparotomy patients over a period of 10 years. Chirurg 73(5):474–80
pubmed: 12089832
doi: 10.1007/s00104-002-0425-5
Deerenberg EB, Harlaar JJ, Steyerberg EW, Lont HE, van Doorn HC, Heisterkamp J et al (2015) Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial. Lancet 386(10000):1254–1260
pubmed: 26188742
doi: 10.1016/S0140-6736(15)60459-7
Millbourn D, Cengiz Y, Israelsson LA (2009) Effect of stitch length on wound complications after closure of midline incisions: a randomized controlled trial. Arch Surg 144(11):1056–1059
pubmed: 19917943
doi: 10.1001/archsurg.2009.189
Beadles CA, Meagher AD, Charles AG (2015) Trends in emergent hernia repair in the United States. JAMA Surg 150(3):194–200
pubmed: 25564946
doi: 10.1001/jamasurg.2014.1242
Wehrle CJ, Shukla P, Miller BT, Blake KE, Prabhu AS, Petro CC et al (2023) Incisional hernia rates following midline laparotomy in the obese patient: a retrospective review. Hernia 27(3):557–563
pubmed: 36318389
doi: 10.1007/s10029-022-02688-6
Sneiders D, Yurtkap Y, Kroese LF, Kleinrensink GJ, Lange JF, Gillion JF (2019) Risk factors for incarceration in patients with primary abdominal wall and incisional hernias: a prospective study in 4472 patients. World J Surg 43(8):1906–1913
pubmed: 30980102
doi: 10.1007/s00268-019-04989-x
Davila DG, Parikh N, Frelich MJ, Goldblatt MI (2016) The increased cost of ventral hernia recurrence: a cost analysis. Hernia 20(6):811–817
pubmed: 27350558
doi: 10.1007/s10029-016-1515-5
Shah DK, Patel SJ, Chaudhary SR, Desai NR (2023) Comparative study of onlay versus sublay mesh repair in the management of ventral hernias. Updates Surg. https://doi.org/10.1007/s13304-023-01532-5
doi: 10.1007/s13304-023-01532-5
pubmed: 37195549
Barranquero AG, Villalobos Mori R, Maestre González Y, Protti GP, López Soler G, Villarreal León F et al (2023) Parietex™ composite ventral patch for primary and incisional hernia repair. ANZ J Surg. https://doi.org/10.1111/ans.18524
doi: 10.1111/ans.18524
pubmed: 37231992
Idiz C, Cakir C (2020) Nutritional status and constipation scoring of inguinal hernia patients: a case-control study. Hernia 24(5):1107–1112
pubmed: 31734784
doi: 10.1007/s10029-019-02075-8
Burnett A, Lecompte M-EA, Trabulsi N, Dubé P, Gervais M-K, Trilling B et al (2019) Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study. World J Surg Oncol 17(1):83
pubmed: 31092250
pmcid: 6521370
doi: 10.1186/s12957-019-1618-4
de Boer NL, Brandt-Kerkhof ARM, Madsen EVE, Doukas M, Verhoef C, Burger JWA (2021) The accuracy of the surgical peritoneal cancer index in patients with peritoneal metastases of colorectal cancer. Dig Surg 38(3):205–211
pubmed: 33657551
doi: 10.1159/000513353
Kofoed NG, Falconer H, Vanky H, Johansson H, Abraham-Nordling M, Salehi S (2023) Survival and chance of reversal after intestinal stoma formation during cytoreductive surgery for advanced ovarian cancer; a population-based cohort study. Gynecol Oncol 170:259–265
pubmed: 36738484
doi: 10.1016/j.ygyno.2023.01.030
Feenstra TM, Verberne CJ, Kok NF, Aalbers AGJ (2022) Anastomotic leakage after cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal cancer. Eur J Surg Oncol 48(12):2460–2466
pubmed: 36096855
doi: 10.1016/j.ejso.2022.05.018
Sugarbaker P (2018) Hernia mesh is contraindicated in patients with peritoneal metastases. JSM Surg Proced 1(1):1001
Tzivanakis A, Dayal SP, Arnold SJ, Mohamed F, Cecil TD, Venkatasubramaniam AK et al (2018) Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy. BJS Open 2(6):464–469
pubmed: 30511047
pmcid: 6254008
doi: 10.1002/bjs5.93
Bhangu A, Fitzgerald JE, Singh P, Battersby N, Marriott P, Pinkney T (2013) Systematic review and meta-analysis of prophylactic mesh placement for prevention of incisional hernia following midline laparotomy. Hernia 17(4):445–455
pubmed: 23712289
doi: 10.1007/s10029-013-1119-2